In this study, we found that the combination of CpG (unmethylated cytosine-phosphorothioate-guanosine forms of DNA), a TLR9 agonist, and RT suppresses tumor growth significantly using autochthonous mouse models of STS in which the tumor gradually develops under surveillance by an intact immune system (10, 11). This evidence concerns the gene TLR9 and neoplasm.